IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Cancer Gene Therapy- Impact Score, Overall Ranking, h-index, SJR, Rating, Publisher, ISSN, and Other Important Metrics

Last Updated on May 27, 2022

Impact Score

5.32

h-Index

 90

Rank

 3029

SJR

 1.207

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics

Title Cancer Gene Therapy
Abbreviation Cancer Gene Ther.
Publication Type Journal
Subject Area, Categories, Scope Cancer Research (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)
h-index 90
Overall Rank/Ranking 3029
SCImago Journal Rank (SJR) 1.207
Impact Score 5.32
Publisher Nature Publishing Group
Country United Kingdom
ISSN 14765500, 09291903




Aim and Scope


Cancer Gene Therapy publishes the results of laboratory investigations, preclinical studies, and clinical trials in the field of gene transfer/gene therapy as applied to cancer research. Types of articles published include original research articles, case reports, preliminary communications, review articles in the main fields of drug resistance/sensitivity, gene therapy, tumor suppressor and anti-oncogene therapy, cytokine/tumor immunotherapy, etc., industry perspective, and letters to the editor.


About Cancer Gene Therapy


Cancer Gene Therapy is a journal covering the technologies/fields/categories related to Cancer Research (Q2); Molecular Biology (Q2); Molecular Medicine (Q2). It is published by Nature Publishing Group. The overall rank of Cancer Gene Therapy is 3029. According to SCImago Journal Rank (SJR), this journal is ranked 1.207. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 90. The best quartile for this journal is Q2.

The ISSN of Cancer Gene Therapy journal is 14765500, 09291903. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Cancer Gene Therapy is cited by a total of 886 articles during the last 3 years (Preceding 2021).


Cancer Gene Therapy Impact Score 2021-2022


The impact score (IS) 2021 of Cancer Gene Therapy is 5.32, which is computed in 2022 as per its definition. Cancer Gene Therapy IS is increased by a factor of 0.44 and approximate percentage change is 9.02% when compared to preceding year 2020, which shows a rising trend. The impact score (IS), also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Cancer Gene Therapy Impact Score 2022 Prediction


IS 2021 of Cancer Gene Therapy is 5.32. If the same upward trend persists, impact score may rise in 2022 as well.


Impact Score Trend


Year wise Impact Score (IS) of Cancer Gene Therapy. Based on Scopus data.


Year Impact Score (IS)
2022/2023 Coming Soon
2021 5.32
2020 4.88
2019 3.98
2018 4.65
2017 3.94
2016 3.59
2015 2.80
2014 2.84

Cancer Gene Therapy h-index


  Table Setting

Cancer Gene Therapy has an h-index of 90. It means 90 articles of this journal have more than 90 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Cancer Gene Therapy ISSN


The ISSN of Cancer Gene Therapy is 14765500, 09291903. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Cancer Gene Therapy Rank and SCImago Journal Rank (SJR)


The overall rank of Cancer Gene Therapy is 3029. According to SCImago Journal Rank (SJR), this journal is ranked 1.207. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


Cancer Gene Therapy Publisher


Table Setting

Cancer Gene Therapy is published by Nature Publishing Group. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 1994-2021. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Cancer Gene Therapy is Cancer Gene Ther.. This abbreviation ('Cancer Gene Ther.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Cancer Gene Therapy


If your research field is/are related to Cancer Research (Q2); Molecular Biology (Q2); Molecular Medicine (Q2), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Pakistan Journal of Engineering and Applied Sciences journal 23402 University of Engineering and Technology, Lahore 4 0.36
Learning Environments Research journal 4411 Springer Netherlands 39 3.45
Environmental Epigenetics journal 3678 Oxford University Press 21 3.42
International Journal of Social Psychiatry journal 1517 SAGE Publications Ltd 68 10.84
Biometrical Journal journal 4401 Wiley-VCH Verlag 66 1.48
E-Journal of International and Comparative Labour Studies journal 22292 2 0.17
International Journal of Power Electronics journal 22723 Inderscience Publishers 13 0.36
Scrutiny2 journal 24574 Taylor and Francis Ltd. 10 0.18
Advances in Applied Probability journal 7621 Cambridge University Press 59 1.13
Nutrition and Cancer journal 8890 Routledge 120 2.81

Check complete list




Year wise Impact Score (IS) of Cancer Gene Therapy

Impact Score Table

Year Impact Score (IS)
2022/2023 Coming Soon
2021 5.32
2020 4.88
2019 3.98
2018 4.65
2017 3.94
2016 3.59
2015 2.80
2014 2.84



Top Journals/Conferences in Cancer Research

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Journal of Clinical Oncology
American Society of Clinical Oncology | United States

JAMA Oncology
American Medical Association | United States

Cell Host and Microbe
Cell Press | United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

Journal of the National Cancer Institute
Oxford University Press | United Kingdom

Annual Review of Cancer Biology
Annual Reviews Inc. | United States

Clinical Cancer Research
American Association for Cancer Research Inc. | United States

Journal for ImmunoTherapy of Cancer
BioMed Central Ltd. | United Kingdom

See All

Top Journals/Conferences in Molecular Biology

Nature Reviews Molecular Cell Biology
Nature Publishing Group | United Kingdom

Cell
Cell Press | United States

Nature Reviews Genetics
Nature Publishing Group | United Kingdom

Nature Medicine
Nature Publishing Group | United Kingdom

Nature Methods
Nature Publishing Group | United Kingdom

Physiological Reviews
American Physiological Society | United States

Molecular Cell
Cell Press | United States

Annual Review of Plant Biology
Annual Reviews Inc. | United States

Cell Metabolism
Cell Press | United States

Nature Structural and Molecular Biology
Nature Publishing Group | United Kingdom

See All

Top Journals/Conferences in Molecular Medicine

Nature Biotechnology
Nature Publishing Group | United Kingdom

Cell Stem Cell
Cell Press | United States

Pharmacological Reviews
American Society for Pharmacology and Experimental Therapeutics | United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

Genome Medicine
BioMed Central Ltd. | United Kingdom

Journal for ImmunoTherapy of Cancer
BioMed Central Ltd. | United Kingdom

EMBO Molecular Medicine
Wiley-Blackwell | United Kingdom

Molecular Therapy
Cell Press | United States

Trends in Molecular Medicine
Elsevier Ltd. | United Kingdom

Molecular Aspects of Medicine
Elsevier Ltd. | United Kingdom

See All